Loading…

Loading grant details…

Completed H2020 European Commission

Regeneration of Injured Spinal cord by Electro pUlsed bio-hybrid imPlant

€3M EUR

Funder European Commission
Recipient Organization Agenzia Nazionale Per Le Nuove Tecnologie, L'Energia E Lo Sviluppo Economico Sostenibile
Country Italy
Start Date May 01, 2021
End Date Apr 30, 2025
Duration 1,460 days
Number of Grantees 7
Roles Coordinator; Participant; Principal Investigator
Data Source European Commission
Grant ID 964562
Grant Description

Spinal Cord Injury (SCI), a major cause of paralysis, currently has no effective therapies. Every year almost 500.000 people are diagnosed with SCI worldwide. In Europe, the average investment is up to 2 M€ per patient in health care.

The difficulty on the neuronal restoration after SCI is based on the complex cascade of events that inexorably cause a degenerative chronic stage mainly favored by the non-permissive environment and limited capacity for axonal regrowth.

Multifaceted strategies are considered the unique solution for functional restoration by including cell substitution, neuroprotection and axonal growth promotion.

RISEUP proposes to attain neuronal functional regeneration after SCI by an unprecedented and unique bio-hybrid-compatible electro-activated and wireless-rechargeable implantable technology.

RISEUP introduces high voltage microsecond electric pulses (micropulses) stimulations and low amplitude direct currents on a combination of stem cells (induced neural stem cells and multipotent stromal cells), whose transplantation is facilitated by an innovative scaffold biomaterial.

The RISEUP concept is that micropulses, being able to impose and control cytosolic Calcium oscillations, will facilitate cell maturation, survival and neurotrophic factors secretion. Because Calcium signaling is essential for neuronal activity, endogenous neuronal re-connections will also be favored.

RISEUP goal, even if ambitious, is concrete due to the multidisciplinary partners’ competences, initiating from TRL1 a radically new line of technology (electro-activated, remotely controlled, biocompatible, biodegradable cell-containing implants for the repair of neuronal lesions) establishing its proof-of-principle (TRL3).

The long-term vision of RISEUP is the radical change in SCI treatment modality to assure the cure delivery without any machinery connection, dramatically improving patients’ quality of life.

All Grantees

Agenzia Nazionale Per Le Nuove Tecnologie, L'Energia E Lo Sviluppo Economico Sostenibile; Rise Technology Srl; Fundacion de la Comunidad Valenciana Centro de Investigacion Principefelipe; Universitat Politecnica de Valencia; Centre National de la Recherche Scientifique CNRS; Universita Degli Studi Di Roma la Sapienza; Carnegie-Mellon University

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant